In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone.
UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
Eminent biotechnology innovator and entrepreneur Gene Lay has committed $25 million through the through the Laygend Foundation to name the Department of Bioengineering in honor of his mentor, Professor Emeritus Shu Chien.
Achyuta Adhvaryu has been appointed as the inaugural director of the UC San Diego School of Global Policy and Strategy India Center and will serve as professor of economics at the school effective Jan. 1, 2023.
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
A globalized, open trade supply chain saved countries an estimated $67 billion in solar panel production costs, reveals a new study published in the Oct. 26 issues of the journal Nature. The savings alone for the United States amounted to $24 billion.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
